Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Buchsbaum

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Cancer Research|May 1, 1988
Localization and imaging with radioiodine-labeled monoclonal antibodies in a xenogeneic tumor model for human B-cell lymphomaD J Buchsbaum, J A Sinkule, M S Stites, et al.
Oncogene|June 18, 2013
Loss of N-Myc interactor promotes epithelial-mesenchymal transition by activation of TGF-β/SMAD signalingD J Devine, J W Rostas, B J Metge, et al.
Cancer Gene Therapy|April 14, 2009
CRAdRGDflt-IL24 virotherapy in combination with chemotherapy of experimental gliomaL N Kaliberova, V Krendelchtchikova, D K Harmon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 1999
Targeting strategies for cancer radiotherapyD J Buchsbaum, B E Rogers, M B Khazaeli, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 13, 2000
Combined modality therapy of A431 human epidermoid cancer using anti-EGFr antibody C225 and radiationM N Saleh, K P Raisch, M A Stackhouse, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 1999
In vivo localization of [(111)In]-DTPA-D-Phe1-octreotide to human ovarian tumor xenografts induced to express the somatostatin receptor subtype 2 using an adenoviral vectorB E Rogers, S F McLean, R L Kirkman, et al.
Cancer Chemotherapy and Pharmacology|July 1, 2010
A phase I study evaluating the role of the anti-epidermal growth factor receptor (EGFR) antibody cetuximab as a radiosensitizer with chemoradiation for locally advanced pancreatic cancerJ P Arnoletti, A Frolov, M Eloubeidi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 8, 2001
An adenovirus with enhanced infectivity mediates molecular chemotherapy of ovarian cancer cells and allows imaging of gene expressionA Hemminki, N Belousova, K R Zinn, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 22, 2000
A targetable, injectable adenoviral vector for selective gene delivery to pulmonary endothelium in vivoP N Reynolds, K R Zinn, V D Gavrilyuk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2000
Enhanced apoptosis with combination C225/radiation treatment serves as the impetus for clinical investigation in head and neck cancersJ A Bonner, K P Raisch, H Q Trummell, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Cancer Research|May 1, 1988
Localization and imaging with radioiodine-labeled monoclonal antibodies in a xenogeneic tumor model for human B-cell lymphomaD J Buchsbaum, J A Sinkule, M S Stites, et al.
Oncogene|June 18, 2013
Loss of N-Myc interactor promotes epithelial-mesenchymal transition by activation of TGF-β/SMAD signalingD J Devine, J W Rostas, B J Metge, et al.
Cancer Gene Therapy|April 14, 2009
CRAdRGDflt-IL24 virotherapy in combination with chemotherapy of experimental gliomaL N Kaliberova, V Krendelchtchikova, D K Harmon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 1999
Targeting strategies for cancer radiotherapyD J Buchsbaum, B E Rogers, M B Khazaeli, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 13, 2000
Combined modality therapy of A431 human epidermoid cancer using anti-EGFr antibody C225 and radiationM N Saleh, K P Raisch, M A Stackhouse, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 1999
In vivo localization of [(111)In]-DTPA-D-Phe1-octreotide to human ovarian tumor xenografts induced to express the somatostatin receptor subtype 2 using an adenoviral vectorB E Rogers, S F McLean, R L Kirkman, et al.
Cancer Chemotherapy and Pharmacology|July 1, 2010
A phase I study evaluating the role of the anti-epidermal growth factor receptor (EGFR) antibody cetuximab as a radiosensitizer with chemoradiation for locally advanced pancreatic cancerJ P Arnoletti, A Frolov, M Eloubeidi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 8, 2001
An adenovirus with enhanced infectivity mediates molecular chemotherapy of ovarian cancer cells and allows imaging of gene expressionA Hemminki, N Belousova, K R Zinn, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 22, 2000
A targetable, injectable adenoviral vector for selective gene delivery to pulmonary endothelium in vivoP N Reynolds, K R Zinn, V D Gavrilyuk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2000
Enhanced apoptosis with combination C225/radiation treatment serves as the impetus for clinical investigation in head and neck cancersJ A Bonner, K P Raisch, H Q Trummell, et al.
Pageof 10